3rd Circ. Questions Early End To Lipitor Pay-For-Delay Suit
A Third Circuit panel repeatedly questioned whether a lower court judge acted prematurely when he ended a lawsuit accusing Pfizer and Ranbaxy of engaging in a pay-for-delay scheme over the cholesterol...To view the full article, register now.
Already a subscriber? Click here to view full article